p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53

Oncogene

Volumn 18, Issue 11, 1999, Pages 1921-1934

  Wasylyk, Christine ^a   Salvi, Roberto ^a   Argentini, Manuela ^a   Dureuil, Christine ^b   Delumeau, Isabelle ^b   Abecassis, Joseph ^c   Debussche, Laurent ^b   Wasylyk, Bohdan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b SANOFI   (France)

^c Laboratoire de Biologie Tumorale   (France)

Author keywords

Antisense; Apoptosis; Cell cycle; E2F; E6; p21(WAF1 CIP1)

Indexed keywords

PEPTIDE; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE; CELL DEATH; COLONY FORMATION; COMPLEX FORMATION; CONTROLLED STUDY; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

EID: 0033580435     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202528     Document Type: Article

References (96)

1. Alkhalaf M, Ganguli G, Messaddeq N, Le Meur M and Wasylyk B. (1998). Oncogene, (in press).
2. Almog N and Rotter V. (1997). Biochim. Biophys. Acta., 1333, F1-27.
3. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM. (1998). Nature, 392, 405-408.
4. Andera L and Wasylyk B. (1997). Mol. Med., 3, 852-863.
5. Barak Y, Gottlieb E, Juven-Gershon T and Oren M. (1994). Genes Dev., 8, 1739-1749.
6. Bernards R. (1997). Biochim. Biophys. Acta., 1333, M33-M40.
7. Blaydes JP, Gire V, Rowson JM and Wynford-Thomas D. (1997). Oncogene, 14, 1859-1868.
8. Bottger A, Bottger V, Garcia-Echeverria C, Chene P, Hochkeppel HK, Sampson W, Ang K, Howard SF, Picksley SM and Lane DP. (1997). J. Mol. Biol., 269, 744-756.
9. Bottger V, Bottger A, Howard SF, Picksley SM, Chene P, Garcia-Echeverria C, Hochkeppel HK and Lane DP. (1996). Oncogene, 13, 2141-2147.
10. Brugidou J, Legrand C, Mery J and Rabie A. (1995). Biochem. Biophys. Res. Commun., 214, 685-693.
11. Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B and Stanbridge EJ. (1991). Oncogene, 6, 1791-1797.
12. Chatton B, Bahr A, Acker J and Kedinger C. (1995). Biotechniques, 18, 142-145.
13. Chen J, Wu X, Lin J and Levine AJ. (1996). Mol. Cell Biol., 16, 2445-2452.
14. Chen L, Agrawal S, Zhou W, Zhang R and Chen J. (1998). Proc. Natl. Acad. Sci. USA, 95, 195-200.
15. Conseiller E, Debussche L, Landais D, Venot C, Maratrat M, Sierra V, Tocque B and Bracco L. (1998). J. Clin. Invest., 101, 120-127.
16. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ. (1994). Cancer Res., 54, 794-799.
17. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. (1998). Genes Dev., 12, 2434-2442.
18. Dubs-Poterszman MC, Tocque B and Wasylyk B. (1995). Oncogene, 11, 2445-2449.
19. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
20. Elenbaas B, Dobbelstein M, Roth J, Shenk T and Levine AJ. (1996). Mol. Med., 2, 439-451.
21. Fiddler TA, Smith L, Tapscott SJ and Thayer MJ. (1996). Mol. Cell Biol., 16, 5048-5057.
22. Finlay CA. (1993). Mol. Cell Biol., 13, 301-306.
23. Florenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O and Fodstad O. (1994). J. Natl. Cancer Inst., 86, 1297-1302.
24. Funk WD, Pak DT, Karas RH, Wright WE and Shay JW. (1992). Mol. Cell Biol., 12, 2866-2871.
25. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. (1996). Nature, 379, 88-91.
26. Haines DS. (1997). Leuk. Lymphoma, 26, 227-238.
27. Hall PA and Lane DP. (1997). Curr. Biol., 7, R144-R147.
28. Hansen R and Oren M. (1997). Curr. Opin. Genet. Dev., 7, 46-51.
29. Haupt Y, Barak Y and Oren M. (1996). EMBO J., 15, 1596-1606.
30. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
31. Hinds PW, Finlay CA, Frey AB and Levine AJ. (1987). Mol. Cell Biol., 7, 2863-2869.
32. Hollstein M, Soussi T, Thomas G, von Brevern MC and Bartsch 2nd. (1997). Recent Results Cancer Res., 143, 369-389.
33. Hsieh JK, Fredersdorf S, Kouzarides T, Martin K and Lu X. (1997). Genes Dev., 11, 1840-1852.
34. Johnson DG and Schneider-Broussard R. (1998). Front Biosci., 3, d447-d448.
35. Jones SN, Roe AE, Donehower LA and Bradley A. (1995). Nature, 378, 206-208.
36. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 3411-3416.
37. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 8292-8297.
38. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
39. Kondo S, Barnett GH, Hara H, Morimura T and Takeuchi J. (1995). Oncogene, 10, 2001-2006.
40. Kondo S, Morimura T, Barnett GH, Kondo Y, Peterson JW, Kaakaji R, Takeuchi J, Toms SA, Liu JB, Werbel B and Barna BP. (1996). Oncogene, 13, 1773-1779.
41. Kowalik TF, DeGregori J, Schwarz JK and Nevins JR. (1995). J. Virol., 69, 2491-2500.
42. Kowalik TF, DeGregori J, Leone G, Jakoi L and Nevins JR. (1998). Cell Growth Differ., 9, 113-118.
43. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
44. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ and Pavletich NP. (1996). Science, 274, 948-953.
45. Landers JE, Haines DS, Strauss JF and George DL. (1994). Oncogene, 9, 2745-2750.
46. Landers JE, Cassel SL and George DL. (1997). Cancer Res., 57, 3562-3568.
47. Lane DP and Hall PA. (1997). Trends Biochem. Sci., 22, 372-374.
48. Levine AJ. (1997). Cell, 88, 323-331.
49. Léveillard T and Wasylyk B. (1997). J. Biol. Chem., 272, 30651-30661.
50. Léveillard T, Gorry P, Niederreither K and Wasylyk B. (1998). Mech. Dev., 74, 189-193.
51. Linke SP, Clarkin KC, Di Leonardo A, Tsou A and Wahl GM. (1996). Genes Dev., 10, 934-947.
52. Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP and Finlay CA. (1997). Genes Dev., 11, 714-725.
53. Maira SM, Wurtz JM and Wasylyk B. (1996). EMBO J., 15, 5849-5865.
54. Marechal V, Elenbaas B, Piette J, Nicolas JC and Levine AJ. (1994). Mol. Cell Biol., 14, 7414-7420.
55. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB and Kouzarides T. (1995). Nature, 375, 691-694.
56. Mayo LD, Turchi JJ and Berberich SJ. (1997). Cancer Res., 57, 5013-5016.
57. Midgley CA and Lane DP. (1997). Oncogene, 15, 1179-1189.
58. Minn AJ, Boise LH and Thompson CB. (1996). Genes Dev., 10, 2621-2631.
59. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
60. Momand J and Zambetti GP. (1996). Oncogene, 12, 2279-2289.
61. Momand J and Zambetti GP. (1997). J. Cell Biochem., 64, 343-352.
62. Montes de Oca Luna R, Wagner DS and Lozano G. (1995). Nature, 378, 203-206.
63. Morgan SE and Kastan MB. (1997). Adv. Cancer Res., 71, 1-25.
64. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL and Wells PG. (1995). Nat. Genet., 10, 181-187.
65. O'Connor DJ, Lam EW, Griffin S, Zhong S, Leighton LC, Burbidge SA and Lu X. (1995). EMBO J., 14, 6184-6192.
66. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B. (1992). Nature 358, 80-83.
67. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
68. Phillips AC, Bates S, Ryan KM, Helin K and Vousden KH. (1997). Genes Dev., 11, 1853-1863.
69. Picksley SM, Spicer JF, Barnes DM and Lane DP. (1996). Acta Oncol., 35, 429-434.
70. Piette J, Neel H and Marechal V. (1997). Oncogene, 15, 1001-1010.
71. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. (1998). Cell, 92, 713-723.
72. Qin XQ, Livingston DM, Kaelin Jr, WG and Adams PD. (1994). Proc. Natl. Acad. Sci. USA, 91, 10918-10922.
73. Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ. (1998). EMBO J., 17, 554-564.
74. Sakai E and Tsuchida N. (1992). Oncogene, 7, 927-933.
75. Scheffner M, Munger K, Byrne JC and Howley PM. (1991). Proc. Natl. Acad. Sci. USA, 88, 5523-5527.
76. Shan B and Lee WH. (1994). Mol. Cell Biol., 14, 8166-8173.
77. Shaulian E, Resnitzky D, Shifman O, Blandino G, Amsterdam A, Yayon A and Oren M. (1997). Oncogene, 15, 2717-2725.
78. Shieh SY, Ikeda M, Taya Y and Prives C. (1997). Cell, 91, 325-334.
79. Sigalas I, Calvert AH, Anderson JJ, Neal DE and Lunec J. (1996). Nat. Med., 2, 912-917.
80. Sorensen TS, Girling R, Lee CW, Gannon J, Bandara LR and La Thangue NB. (1996). Mol. Cell Biol., 16, 5888-5895.
81. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. (1998). EMBO J., 17, 5001-5014.
82. Teoh G, Urashima M, Ogata A, Chauhan D, DeCaprio JA, Treon SP, Schlossman RL and Anderson KC. (1997). Blood, 90, 1982-1992.
83. Wang XW and Harris CC. (1997). J. Cell Physiol., 173, 247-255.
84. Wasylyk C, Imler JL and Wasylyk B. (1988). EMBO J., 7, 2475-2483.
85. Wasylyk C, Bradford AP, Gutierrez-Hartmann A and Wasylyk B. (1997). Oncogene, 14, 899-913.
86. Wu X, Bayle JH, Olson D and Levine AJ. (1993). Genes Dev., 7, 1126-1132.
87. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
88. Wubah JA, Ibrahim MM, Gao X, Nguyen D, Pisano MM and Knudsen TB. (1996). Curr. Biol., 6, 60-69.
89. Wurl P, Meye A, Schmidt H, Lautenschlager C, Kalthoff H, Rath FW and Taubert H. (1998). Oncogene, 16, 1183-1185.
90. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM. (1995). Nature, 375, 694-698.
91. Yaginuma Y and Westphal H. (1991). Cancer Res., 51, 6506-6509.
92. Zamanian M and La Thangue NB. (1992). EMBO J., 11, 2603-2610.
93. Zauberman A, Flusberg D, Haupt Y, Barak Y and Oren M. (1995). Nucleic Acids Res., 23, 2584-2592.
94. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.
95. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N and Harlow E. (1993). Genes Dev., 7, 1111-1125.
96. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.